Skip to main content
Erschienen in: Supportive Care in Cancer 6/2018

12.01.2018 | Original Article

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial

verfasst von: Catherine E. Mosher, Ekin Secinti, Ruohong Li, Adam T. Hirsh, Jonathan Bricker, Kathy D. Miller, Bryan Schneider, Anna Maria Storniolo, Lida Mina, Erin V. Newton, Victoria L. Champion, Shelley A. Johns

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Breast cancer is the leading cause of cancer mortality in women worldwide. With medical advances, metastatic breast cancer (MBC) patients often live for years with many symptoms that interfere with activities. However, there is a paucity of efficacious interventions to address symptom-related suffering and functional interference. Thus, this study examined the feasibility and preliminary efficacy of telephone-based acceptance and commitment therapy (ACT) for symptom interference with functioning in MBC patients.

Methods

Symptomatic MBC patients (N = 47) were randomly assigned to six telephone sessions of ACT or six telephone sessions of education/support. Patients completed measures of symptom interference and measures assessing the severity of pain, fatigue, sleep disturbance, depressive symptoms, and anxiety.

Results

The eligibility screening rate (64%) and high retention (83% at 8 weeks post-baseline) demonstrated feasibility. When examining within-group change, ACT participants showed decreases in symptom interference (i.e., fatigue interference and sleep-related impairment; Cohen’s d range = − 0.23 to − 0.31) at 8 and 12 weeks post-baseline, whereas education/support participants showed minimal change in these outcomes (d range = − 0.03 to 0.07). Additionally, at 12 weeks post-baseline, ACT participants showed moderate decreases in fatigue and sleep disturbance (both ds = − 0.43), whereas education/support participants showed small decreases in these outcomes (ds = − 0.24 and − 0.18 for fatigue and sleep disturbance, respectively). Both the ACT and education/support groups showed reductions in depressive symptoms (ds = − 0.27 and − 0.28) at 12 weeks post-baseline. Group differences in all outcomes were not statistically significant.

Conclusions

ACT shows feasibility and promise in improving fatigue and sleep-related outcomes in MBC patients and warrants further investigation.
Literatur
8.
Zurück zum Zitat Lam WWT, Tsang J, Yeo W, Suen J, Ho WM, Yau TK, Soong I, Wong KY, Kwong A, Suen D, Sze WK, Ng AWY, Girgis A, Fielding R (2013) The evolution of supportive care needs trajectories in women with advanced breast cancer during the 12 months following diagnosis. Support Care Cancer 22:635–644CrossRefPubMed Lam WWT, Tsang J, Yeo W, Suen J, Ho WM, Yau TK, Soong I, Wong KY, Kwong A, Suen D, Sze WK, Ng AWY, Girgis A, Fielding R (2013) The evolution of supportive care needs trajectories in women with advanced breast cancer during the 12 months following diagnosis. Support Care Cancer 22:635–644CrossRefPubMed
9.
Zurück zum Zitat Grabsch B, Clarke DM, Love A, McKenzie DP, Snyder RD, Bloch S, Smith G, Kissane DW (2006) Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care 4(1):47–56CrossRefPubMed Grabsch B, Clarke DM, Love A, McKenzie DP, Snyder RD, Bloch S, Smith G, Kissane DW (2006) Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care 4(1):47–56CrossRefPubMed
13.
Zurück zum Zitat McGuire DB, Sheidler VR (1992) Pain. In: Groenwald SL, Frogge MH, Goodman M, Yarbro CH (eds) Manifestations of cancer and cancer treatment. Jones and Bartlett Publishers, Boston, pp 441–985 McGuire DB, Sheidler VR (1992) Pain. In: Groenwald SL, Frogge MH, Goodman M, Yarbro CH (eds) Manifestations of cancer and cancer treatment. Jones and Bartlett Publishers, Boston, pp 441–985
14.
Zurück zum Zitat Mustafa M, Carson-Stevens S, Gillespie D, Edwards AGK (2013) Psychological interventions for women with metastatic breast cancer (review). Cochrane Database Syst Rev 6:CD004253 Mustafa M, Carson-Stevens S, Gillespie D, Edwards AGK (2013) Psychological interventions for women with metastatic breast cancer (review). Cochrane Database Syst Rev 6:CD004253
16.
Zurück zum Zitat Hayes SC, Strosahl KD, Wilson KG (2012) Acceptance and commitment therapy, second edition: the process and practice of mindful change. Guilford Press, New York Hayes SC, Strosahl KD, Wilson KG (2012) Acceptance and commitment therapy, second edition: the process and practice of mindful change. Guilford Press, New York
25.
27.
Zurück zum Zitat Hayes SC, Smith S (2005) Get out of your mind and into your life: the new acceptance and commitment therapy. New Harbinger, Oakland Hayes SC, Smith S (2005) Get out of your mind and into your life: the new acceptance and commitment therapy. New Harbinger, Oakland
28.
Zurück zum Zitat Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63(11):1179–1194. https://doi.org/10.1016/j.jclinepi.2010.04.011 CrossRefPubMedPubMedCentral Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63(11):1179–1194. https://​doi.​org/​10.​1016/​j.​jclinepi.​2010.​04.​011 CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E (2012) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23:vii11–vii19CrossRefPubMed Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E (2012) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23:vii11–vii19CrossRefPubMed
40.
Zurück zum Zitat Mosher CE, Winger JG, Hanna N, Jalal SI, Einhorn LH, Birdas TJ, Ceppa DP, Kesler KA, Schmitt J, Kashy DA, Champion VL (2016) Randomized pilot trial of a telephone symptom management intervention for symptomatic lung cancer patients and their family caregivers. J Pain Symptom Manag 52:469–482 PMCID: PMC5075493CrossRef Mosher CE, Winger JG, Hanna N, Jalal SI, Einhorn LH, Birdas TJ, Ceppa DP, Kesler KA, Schmitt J, Kashy DA, Champion VL (2016) Randomized pilot trial of a telephone symptom management intervention for symptomatic lung cancer patients and their family caregivers. J Pain Symptom Manag 52:469–482 PMCID: PMC5075493CrossRef
44.
Zurück zum Zitat Johns SA, Brown LF, Beck-Coon K, Talib TL, Monahan PO, Giesler RB, Tong Y, Wilhelm L, Carpenter JS, Von AD, Wagner CD, de Groot M, Schmidt K, Monceski D, Danh M, Alyea JM, Miller KD, Kroenke K (2016) Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors. Support Care Cancer 24(10):4085–4096. https://doi.org/10.1007/s00520-016-3220-4 CrossRefPubMedPubMedCentral Johns SA, Brown LF, Beck-Coon K, Talib TL, Monahan PO, Giesler RB, Tong Y, Wilhelm L, Carpenter JS, Von AD, Wagner CD, de Groot M, Schmidt K, Monceski D, Danh M, Alyea JM, Miller KD, Kroenke K (2016) Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors. Support Care Cancer 24(10):4085–4096. https://​doi.​org/​10.​1007/​s00520-016-3220-4 CrossRefPubMedPubMedCentral
Metadaten
Titel
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial
verfasst von
Catherine E. Mosher
Ekin Secinti
Ruohong Li
Adam T. Hirsh
Jonathan Bricker
Kathy D. Miller
Bryan Schneider
Anna Maria Storniolo
Lida Mina
Erin V. Newton
Victoria L. Champion
Shelley A. Johns
Publikationsdatum
12.01.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4045-0

Weitere Artikel der Ausgabe 6/2018

Supportive Care in Cancer 6/2018 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.